Current and Novel Inhibitors of HIV Protease

Current and Novel Inhibitors of HIV Protease

The design, development and clinical success of HIV protease inhibitors represent one of the most remarkable achievements of molecular medicine. This review describes all nine currently available FDA-approved protease inhibitors, discusses their pharmacokinetic properties, off-target activities, sid...

Full description

Bibliographic Details
Main Authors:	Jan Konvalinka, Ladislav Machala, Pavlína Řezáčová, Jana Pokorná
Format:	Article
Language:	English
Published:	MDPI AG 2009-12-01
Series:	Viruses
Subjects:	HIV protease protease inhibitors HAART resistance development pharmacokinetic boosting protease dimerization alternative inhibitors
Online Access:	http://www.mdpi.com/1999-4915/1/3/1209/

Similar Items

Comparison of Preterm Delivery Rates between HIV-infected Pregnant Women Receiving Highly Active Antiretroviral Therapy (HAART) Containing Protease Inhibitors (PIs) and HIV-infected Pregnant Women Receiving Zidovudine Monotherapy
by: Bongkot Chakornbandit, et al.
Published: (2015-09-01)

Prevalence of Dyslipidemia and Metabolic Abnormalities in HIV-Infected Patients
by: Amitis Ramezani, et al.
Published: (2009-04-01)

Prevalence of Dyslipidemia and Metabolic Abnormalities in HIV-Infected Patients
by: Ramezani Amitis, et al.
Published: (2009-05-01)

Modern anti-HIV therapy
by: M Flepp, et al.
Published: (2001-04-01)

Redistribuição da gordura corporal induzida pelos inibidores de protease em pacientes com Aids Redistribution of body fat induced by HIV protease inhibitors in patients with AIDS
by: Cristina Mansur, et al.
Published: (2006-10-01)

Oral candidiasis in HIV+ patients under treatment with protease inhibitors
by: Andréa Lusvarghi Witzel, et al.
Published: (2008-12-01)

HIV Protease: Historical Perspective and Current Research
by: Irene T. Weber, et al.
Published: (2021-05-01)

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors
by: Sunday N. Okafor, et al.
Published: (2023-08-01)

Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease
by: Sibusiso Maseko, et al.
Published: (2019-01-01)

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
by: Unaí Tupinambás, et al.

Potential Associations of Mutations within the HIV-1 <i>Env</i> and <i>Gag</i> Genes Conferring Protease Inhibitor (PI) Drug Resistance
by: Ntombikhona F. Maphumulo, et al.
Published: (2021-12-01)

Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review
by: Callum Stewart-McGuinness, et al.
Published: (2022-03-01)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
by: Chinh Tran-To Su, et al.
Published: (2019-09-01)

Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations
by: Soo-Yon Rhee, et al.
Published: (2022-05-01)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
by: Mohamed Mahdi, et al.
Published: (2020-11-01)

Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
by: Patrícia de Almeida Machado, et al.
Published: (2025-01-01)

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection
by: Winke Van der Gucht, et al.
Published: (2017-08-01)

Host Cell Proteases Involved in Human Respiratory Viral Infections and Their Inhibitors: A Review
by: Bailey Lubinski, et al.
Published: (2024-06-01)

Plant protease inhibitors : significance in nutrition, plant protection, cancer prevention, and genetic engineering /
by: 407348 Birk, Yehudith
Published: (2003)

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
by: Stephan C, et al.
Published: (2010-09-01)

HIV-1 Gag Non-Cleavage Site PI Resistance Mutations Stabilize Protease/Gag Substrate Complexes In Silico via a Substrate-Clamp
by: Gary S. Laco
Published: (2021-11-01)

Premature Activation of the HIV-1 Protease Is Influenced by Polymorphisms in the Hinge Region
by: Caroline O. Tabler, et al.
Published: (2024-05-01)

Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers
by: Amiram Sananes, et al.
Published: (2023-11-01)

Sensing HIV Protease and Its Inhibitor Using “Helical Epitope”—Imprinted Polymers
by: Chien-Yu Chou, et al.
Published: (2020-06-01)

Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch
by: Simeon Eche, et al.
Published: (2021-03-01)

Identification of Proteases and Protease Inhibitors in Seeds of the Recalcitrant Forest Tree Species Quercus ilex
by: Monica Escandón, et al.
Published: (2022-06-01)

A cysteine protease inhibitor GC376 displays potent antiviral activity against coxsackievirus infection
by: Yongkang Chen, et al.
Published: (2023-01-01)

The complex world of plant protease inhibitors: Insights into a Kunitz-type cysteine protease inhibitor of Arabidopsis thaliana
by: Sachin Rustgi, et al.
Published: (2018-01-01)

AI-Aided Search for New HIV-1 Protease Ligands
by: Roberto Arrigoni, et al.
Published: (2023-05-01)

Treatment Outcome and Regimens of Lipid-Lowering Drugs among HIV-Infected Patients Receiving Protease Inhibitors
by: Krisda Boonthos, et al.
Published: (2016-10-01)

HIV Protease Inhibitors and Insulin Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Violet Dismas Kajogoo, et al.
Published: (2021-11-01)

Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors
by: Rishikesh Lotke, et al.
Published: (2024-02-01)

Exploring the Potential of Bacillus Species Secondary Metabolites as SARS-CoV-2 Protease Inhibitors
by: Yuniar Mulyani, et al.
Published: (2024-06-01)

HIV-1 Protease: Structural Perspectives on Drug Resistance
by: Irene T. Weber, et al.
Published: (2009-12-01)

Molecular cloning, functional assessment and transcriptome characterization of cysteine protease inhibitor and kunitz trypsin inhibitor from turmeric (Curcuma longa L.)
by: Chan, Seow Neng
Published: (2016)

Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
by: Ean Spielvogel, et al.
Published: (2023-03-01)

Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal–fetal interface in pigs
by: Soohyung Lee, et al.
Published: (2023-07-01)

Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury
by: Kantapich Kongpol, et al.
Published: (2019-10-01)

Design and Synthesis of Cysteine Proteases Inhibitors
by: Florenci V. Gonzalez
Published: (2019-08-01)

The Place of protease inhibitors in antiretroviral treatment
by: S.B. Tenore, et al.